TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Massachusetts Investigators

Toni Choueiri, MD

Dana-Farber Cancer Institute


Boston, Massachusetts - 02115

Dana-Farber/Harvard Cancer Center at Dana ...


Boston, Massachusetts - 02115 (617-632-4001)
  • CLINICAL TRIALS 6
  • CONDITIONS8
  • INTERVENTIONS14
  • SINCE2007
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

January 2009 - September 2010
Arterial Spin Labeling Blood Flow MRI for Evaluation of Response to Antiangiogenic and Targeted Therapies of Renal Cell Carcinoma (RCC)

September 2008 - September 2010
Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

December 2007 - December 2011
Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

December 2008 - December 2010
Docetaxel With or Without Vandetanib in Treating Patients With Previously Treated Stage IV Transitional Cell Cancer

March 2007 - March 2010
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

March 2009 - January 2011
Neoplasms

Neoplasm Metastasis

Urinary Bladder Neoplasms

Carcinoma, Renal Cell

Kidney Neoplasms

Carcinoma

Carcinoma, Transitional Cell

Ureteral Neoplasms

Placebo

Cisplatin

Docetaxel

Methotrexate

Avastin

Temsirolimus

Everolimus

Gemcitabine

Pegfilgrastim

Sunitinib

Doxorubicin

Arterial Spin Labeling Magnetic Resonance Imaging

Vinblastine

Vandetanib

©2013 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo